Supportive care and osteopathic medicine in pediatric oncology: perspectives of current oncology clinicians, caregivers, and patients.
Integrative medicine
Oncology
Osteopathic
Pediatric
Journal
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
11
03
2020
accepted:
26
06
2020
pubmed:
11
7
2020
medline:
5
2
2021
entrez:
11
7
2020
Statut:
ppublish
Résumé
Many children receiving chemotherapy struggle with therapy-induced side effects. To date, there has been no literature investigating the needs, knowledge, or implementation of osteopathic manipulative treatments (OMT) as a supportive care option in pediatric oncology. We hypothesized that pediatric oncology clinicians, caregivers, and patients have (a) limited knowledge of OMT and (b) dissatisfaction with current supportive care options and (c) would be interested in having OMT available during chemotherapy, once educated. Participants included three cohorts: (1) children aged ≥ 9 years, diagnosed with cancer and actively receiving chemotherapy; (2) their caregivers; and (3) oncology clinicians at Nationwide Children's Hospital. Participants completed 1:1 semi-structured interviews, which were audio-recorded, transcribed, and analyzed for thematic content regarding their perception of supportive care measures and views on OMT. Quantitative data was summarized descriptively. A total of 60 participants completed the interview. Participants demonstrated limited awareness of osteopathic medicine; no participant had more than "some" knowledge of OMT. After education about OMT using a brief video, all clinicians, caregivers, and 95% of patients were receptive to OMT as a supportive care option. Major themes included the following: (a) patients have uncontrolled chemotherapy side effects, (b) improved supportive care options are desired, and (c) osteopathic medicine is a favorable supportive care adjunct. Pediatric oncology clinicians, caregivers, and patients reported a need for better management of chemotherapy-associated side effects and an interest in utilizing OMT. These findings support further investigation into the safety, feasibility, and efficacy of implementing OMT in the pediatric oncology clinical setting.
Sections du résumé
BACKGROUND AND OBJECTIVE
OBJECTIVE
Many children receiving chemotherapy struggle with therapy-induced side effects. To date, there has been no literature investigating the needs, knowledge, or implementation of osteopathic manipulative treatments (OMT) as a supportive care option in pediatric oncology. We hypothesized that pediatric oncology clinicians, caregivers, and patients have (a) limited knowledge of OMT and (b) dissatisfaction with current supportive care options and (c) would be interested in having OMT available during chemotherapy, once educated.
METHODS
METHODS
Participants included three cohorts: (1) children aged ≥ 9 years, diagnosed with cancer and actively receiving chemotherapy; (2) their caregivers; and (3) oncology clinicians at Nationwide Children's Hospital. Participants completed 1:1 semi-structured interviews, which were audio-recorded, transcribed, and analyzed for thematic content regarding their perception of supportive care measures and views on OMT. Quantitative data was summarized descriptively.
RESULTS
RESULTS
A total of 60 participants completed the interview. Participants demonstrated limited awareness of osteopathic medicine; no participant had more than "some" knowledge of OMT. After education about OMT using a brief video, all clinicians, caregivers, and 95% of patients were receptive to OMT as a supportive care option. Major themes included the following: (a) patients have uncontrolled chemotherapy side effects, (b) improved supportive care options are desired, and (c) osteopathic medicine is a favorable supportive care adjunct.
CONCLUSIONS
CONCLUSIONS
Pediatric oncology clinicians, caregivers, and patients reported a need for better management of chemotherapy-associated side effects and an interest in utilizing OMT. These findings support further investigation into the safety, feasibility, and efficacy of implementing OMT in the pediatric oncology clinical setting.
Identifiants
pubmed: 32647995
doi: 10.1007/s00520-020-05612-9
pii: 10.1007/s00520-020-05612-9
pmc: PMC7767897
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1121-1128Subventions
Organisme : Research Institute, Nationwide Children's Hospital
ID : AWD00000540
Références
Collins JJ, Devine TD, Dick GS, Johnson EA, Kilham HA, Pinkerton CR, Stevens MM, Thaler HT, Portenoy RK (2002) The measurement of symptoms in young children with cancer: the validation of the memorial symptom assessment scale in children aged 7–12. J Pain Symptom Manag 23(1):10–16. https://doi.org/10.1016/S0885-3924(01)00375-X
doi: 10.1016/S0885-3924(01)00375-X
Hedström M, Ljungman G, Von Essen L (2005) Perceptions of distress among adolescents recently diagnosed with cancer. J Pediatr Hematol Oncol 27(1):15–22. https://doi.org/10.1097/01.mph.0000151803.72219.ec
doi: 10.1097/01.mph.0000151803.72219.ec
pubmed: 15654273
Elzagallaai AA, Greff M, Rieder MJ (2017) Adverse drug reactions in children: the double-edged sword of therapeutics. Clin Pharmacol Ther 101(6):725–735. https://doi.org/10.1002/cpt.677
doi: 10.1002/cpt.677
pubmed: 28295234
Gonzales A, Gates E, Bhunia N, Mehyar L, Hashem H, Stanek JR, Krebs B, Auletta JJ (2019) Transplant energize me patient outcome (TEMPO): a quality improvement project that maintains functional mobility in pediatric patients admitted for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 25(9):1779–1785. https://doi.org/10.1016/j.bbmt.2019.05.004
doi: 10.1016/j.bbmt.2019.05.004
pubmed: 31085304
Erdem E, Sezer Efe Y, Bayat M, Uslu N, Sıvacı L, Yılmaz E (2019) Complementary and alternative medicine methods used among Turkish pediatric oncology patients. J Pediatr Nurs 52:e103–e107. https://doi.org/10.1016/j.pedn.2019.11.013
doi: 10.1016/j.pedn.2019.11.013
pubmed: 31822371
Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, Lewith GT (2010) Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125(4):768–776. https://doi.org/10.1542/peds.2009-1775
doi: 10.1542/peds.2009-1775
pubmed: 20308209
Sung L (2015) Priorities for quality care in pediatric oncology supportive care. J Oncol Pract 11(3):187–189. https://doi.org/10.1200/jop.2014.002840
doi: 10.1200/jop.2014.002840
pubmed: 25758449
Health NCfCaI (2019) Complementary, alternative, or integrative health: what’s in a name? Accessed January 22 2020
Shannon SC, Teitelbaum HS (2009) The status and future of osteopathic medical education in the United States. Acad Med 84(6):707–711. https://doi.org/10.1097/ACM.0b013e3181a43be8
doi: 10.1097/ACM.0b013e3181a43be8
pubmed: 19474542
Smith-Kelly JB, Cardenas A (2016) Assessment of hospital Staff's knowledge of osteopathic manipulative medicine: a survey-based study. J Am Osteopath Assoc 116(12):764–769. https://doi.org/10.7556/jaoa.2016.151
doi: 10.7556/jaoa.2016.151
pubmed: 27893142
Di Giovanna EL, Schiowitz S, Dowling DJ (2004) An osteopathic approach to diagnosis and treatment, 3rd edn. Lippincott Williams & Wilkins, Philadelphia
Baltazar GA, Betler MP, Akella K, Khatri R, Asaro R, Chendrasekhar A (2013) Effect of osteopathic manipulative treatment on incidence of postoperative ileus and hospital length of stay in general surgical patients. J Am Osteopath Assoc 113(3):204–209
pubmed: 23485980
Muller A, Franke H, Resch KL, Fryer G (2014) Effectiveness of osteopathic manipulative therapy for managing symptoms of irritable bowel syndrome: a systematic review. J Am Osteopath Assoc 114(6):470–479. https://doi.org/10.7556/jaoa.2014.098
doi: 10.7556/jaoa.2014.098
pubmed: 24917634
Noll DR, Degenhardt BF, Morley TF, Blais FX, Hortos KA, Hensel K, Johnson JC, Pasta DJ, Stoll ST (2010) Efficacy of osteopathic manipulation as an adjunctive treatment for hospitalized patients with pneumonia: a randomized controlled trial. Osteopath Med Prim Care 4:2. https://doi.org/10.1186/1750-4732-4-2
doi: 10.1186/1750-4732-4-2
pubmed: 20302619
pmcid: 2848182
Posadzki P, Lee MS, Ernst E (2013) Osteopathic manipulative treatment for pediatric conditions: a systematic review. Pediatrics 132(1):140–152. https://doi.org/10.1542/peds.2012-3959
doi: 10.1542/peds.2012-3959
pubmed: 23776117
Hayes NM, Bezilla TA (2006) Incidence of iatrogenesis associated with osteopathic manipulative treatment of pediatric patients. J Am Osteopath Assoc 106(10):605–608
pubmed: 17122030
King HH (2016) Osteopathic manipulative therapy is feasible and safe after abdominal surgery. J Am Osteopath Assoc 116(7):489–490. https://doi.org/10.7556/jaoa.2016.098
doi: 10.7556/jaoa.2016.098
pubmed: 27367958
Hickey G, Kipping C (1996) A multi-stage approach to the coding of data from open-ended questions. Nurse Res 4(1):81–91. https://doi.org/10.7748/nr.4.1.81.s9
doi: 10.7748/nr.4.1.81.s9
pubmed: 27707369
Guest G, Bunce A, Johnson L (2006) How many interviews are enough?:an experiment with data saturation and variability. Field Methods 18(1):59–82. https://doi.org/10.1177/1525822x05279903
doi: 10.1177/1525822x05279903
Pashankar FD, Season JH, McNamara J, Pashankar DS (2011) Acute constipation in children receiving chemotherapy for cancer. J Pediatr Hematol Oncol 33(7):e300–e303. https://doi.org/10.1097/MPH.0b013e31821a0795
doi: 10.1097/MPH.0b013e31821a0795
pubmed: 21941132
Wolfe J, Grier HE, Klar N, Levin SB, Ellenbogen JM, Salem-Schatz S, Emanuel EJ, Weeks JC (2000) Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342(5):326–333. https://doi.org/10.1056/nejm200002033420506
doi: 10.1056/nejm200002033420506
pubmed: 10655532
Sitaresmi MN, Mostert S, Gundy C, Sutary S, Veertman A (2007) Chemotherapy-related side effects in childhood acute lymphoblastic leukemia in Indonesia: parental perception. Pediatr Blood Cancer 49(4):526–526
Regnier Denois V, Poirson J, Nourissat A, Jacquin JP, Guastalla JP, Chauvin F (2011) Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists. Eur J Cancer Care 20(4):520–527. https://doi.org/10.1111/j.1365-2354.2010.01212.x
doi: 10.1111/j.1365-2354.2010.01212.x
Burkhart PV, Sabate E (2003) Adherence to long-term therapies: evidence for action. J Nurs Scholarsh 35(3):207
doi: 10.1111/j.1547-5069.2003.tb00001.x
Yun H, Romero SAD, Record B, Kearney J, Raghunathan NJ, Sands S, Mao JJ (2019) Utilization of integrative medicine differs by age among pediatric oncology patients. Pediatr Blood Cancer 66(6):e27639. https://doi.org/10.1002/pbc.27639
doi: 10.1002/pbc.27639
pubmed: 30706689
pmcid: 6866674
Atzori B, Hoffman HG, Vagnoli L, Patterson DR, Alhalabi W, Messeri A, Lauro Grotto R (2018) Virtual reality analgesia during venipuncture in pediatric patients with onco-hematological diseases. Front Psychol 9:2508. https://doi.org/10.3389/fpsyg.2018.02508
doi: 10.3389/fpsyg.2018.02508
pubmed: 30618938
pmcid: 6307499
Schutze T, Langler A, Zuzak TJ, Schmidt P, Zernikow B (2016) Use of complementary and alternative medicine by pediatric oncology patients during palliative care. Support Care Cancer 24(7):2869–2875. https://doi.org/10.1007/s00520-016-3097-2
doi: 10.1007/s00520-016-3097-2
pubmed: 26838025
Magi T, Kuehni CE, Torchetti L, Wengenroth L, Luer S, Frei-Erb M (2015) Use of complementary and alternative medicine in children with cancer: a study at a Swiss University Hospital. PLoS One 10(12):e0145787. https://doi.org/10.1371/journal.pone.0145787
doi: 10.1371/journal.pone.0145787
pubmed: 26694320
pmcid: 4687920
Snider KT, Jorgensen DJ (2009) Billing and coding for osteopathic manipulative treatment. J Am Osteopath Assoc 109(8):409–413. https://doi.org/10.7556/jaoa.2009.109.8.409
doi: 10.7556/jaoa.2009.109.8.409
pubmed: 19706830